Collaborative Care's medication management team is very proud to offer our clients the opportunity to participate in genetic assay testing.
Genetic assay testing, a subfield of behavioral neurogenetics, studies the role of genetics in psychiatric conditions such as anxiety, schizophrenia, bipolar disorder, depression, and autism. The goal of psychiatric genetics is to better understand
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing. Genomind is comprised of pioneering researchers and thought leaders in psychiatry and neurology and specializes in pharmacogenetic laboratory testing for psychiatry. Genomind is committed to partnering with clinicians to improve their patients’ lives. Learn more at www.genomind.com/
GeneSight is a genetic test that helps healthcare providers take a personalized approach to prescribing medicine for patients. Because genes influence the way a person’s body responds to specific medications, they may not work the same for everyone. Using DNA gathered with a simple cheek swab, GeneSight analyzes a patient’s genes and provides individualized information to help healthcare providers select medications that better match their patient’s genes. Multiple clinical studies have shown that when clinicians used GeneSight to help guide treatment decisions, patients were twice as likely to respond to the selected medication. Learn more at www.genesight.com/
SpectraCell Laboratories provides intracellular micronutrient and cardiometabolic testing, driven by state-of-the-art technology, assesses a spectrum of risk factors and biomarkers for optimum wellness. They also provides innovative solutions for hormone health and genetics. Lean more at www.spectracell.com